These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 25403213)
21. Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients. Kuijpers YA; Meijer RP; Jonges GN; de Jong J; Bosch JL; Horenblas S; Bex A World J Urol; 2016 Aug; 34(8):1073-9. PubMed ID: 27055532 [TBL] [Abstract][Full Text] [Related]
22. Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up. Antonelli A; Furlan M; Sodano M; Cindolo L; Belotti S; Tardanico R; Cozzoli A; Zanotelli T; Simeone C Int J Urol; 2016 Jan; 23(1):36-40. PubMed ID: 26567050 [TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma. Hallemeier CL; Choo R; Davis BJ; Pisansky TM; Gunderson LL; Leibovich BC; Haddock MG Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1938-43. PubMed ID: 21514065 [TBL] [Abstract][Full Text] [Related]
24. Is chest imaging needed as part of pT1a renal cell carcinoma surveillance after surgical resection? Charles D; Fitzgerald J; Landowski T; Cooper B; Yong R; Everett R; See W; Jacobsohn K; Johnson S; Langenstroer P Urol Oncol; 2024 Jan; 42(1):23.e1-23.e4. PubMed ID: 38040536 [TBL] [Abstract][Full Text] [Related]
25. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243 [TBL] [Abstract][Full Text] [Related]
26. Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma. Masroor F; Corpman D; Carpenter DM; Ritterman Weintraub M; Cheung KHN; Wang KH JAMA Otolaryngol Head Neck Surg; 2019 Oct; 145(10):903-908. PubMed ID: 31393552 [TBL] [Abstract][Full Text] [Related]
28. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. Ishimura T; Sakai I; Hara I; Eto H; Miyake H Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540 [TBL] [Abstract][Full Text] [Related]
29. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable. Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965 [TBL] [Abstract][Full Text] [Related]
30. Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter study. Kang HW; Lee SK; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ; J Surg Oncol; 2016 Jul; 114(1):70-4. PubMed ID: 27074886 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence. Cohen DD; Matin SF; Steinberg JR; Zagone R; Wood CG J Urol; 2005 May; 173(5):1487-90; discussion 1490-1. PubMed ID: 15821465 [TBL] [Abstract][Full Text] [Related]
32. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. Levy DA; Slaton JW; Swanson DA; Dinney CP J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823 [TBL] [Abstract][Full Text] [Related]
34. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. Stephenson AJ; Chetner MP; Rourke K; Gleave ME; Signaevsky M; Palmer B; Kuan J; Brock GB; Tanguay S J Urol; 2004 Jul; 172(1):58-62. PubMed ID: 15201737 [TBL] [Abstract][Full Text] [Related]
35. 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications. Ward RD; Tanaka H; Campbell SC; Remer EM Radiographics; 2018; 38(7):2021-2033. PubMed ID: 30339517 [TBL] [Abstract][Full Text] [Related]
36. A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. Beisland C; Guðbrandsdottir G; Reisæter LA; Bostad L; Hjelle KM World J Urol; 2016 Aug; 34(8):1087-99. PubMed ID: 26922650 [TBL] [Abstract][Full Text] [Related]
37. Parenchyma-conserving surgery for renal cell carcinoma. Taari K; Salo JO; Rannikko S; Kärkkäinen P; Nordling S; Lehtonen T Ann Chir Gynaecol Suppl; 1993; 206():54-8. PubMed ID: 8291871 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the cost of CA-125 measurement, physical exam, and imaging in the diagnosis of recurrent ovarian cancer. Armstrong A; Otvos B; Singh S; Debernardo R Gynecol Oncol; 2013 Dec; 131(3):503-7. PubMed ID: 24060416 [TBL] [Abstract][Full Text] [Related]
39. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Janzen NK; Kim HL; Figlin RA; Belldegrun AS Urol Clin North Am; 2003 Nov; 30(4):843-52. PubMed ID: 14680319 [TBL] [Abstract][Full Text] [Related]
40. Nurse-led renal cell carcinoma clinic: a single center review. Thia I; Tan A; Botha E; Picardo A; Brown M; Thyer I; Abdul-Hamid A; Tan A; Teichmann D; Hayne D; McCombie SP ANZ J Surg; 2024 Jun; 94(6):1071-1075. PubMed ID: 38426382 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]